AstraZeneca to invest $2.5 billion in Beijing hub as it looks beyond Chinese tax probe
British pharmaceutical giant AstraZeneca announced on Friday that it will invest $2.5 billion in a research and development ...
AstraZeneca to build $2.5B research hub in Beijing
AstraZeneca plans to build a $2.5 billion research and development center in Beijing, the Britain-based multinational ...
Labiotech.eu2d
AstraZeneca bets on Asia: a surge of deals in March amid fraud probe
AstraZeneca has vowed to spend over $10 billion on R&D deals in Asia, focusing on China, amid ongoing fraud scandal ...
AstraZeneca Invests $2.5 Billion in Beijing Hub Amid Probe
AstraZeneca Plc will invest $2.5 billion in a new research center in Beijing, in a major show of commitment to China just ...
AstraZeneca to Invest $2.5 Billion in China Amid Probes
The drugmaker plans to build a research-and-development center in Beijing and strike deals with local biotechnology companies ...
Yahoo Finance13d
AstraZeneca to invest £2bn in Beijing amid China investigation
Pascal Soriot, AstraZeneca’s chief executive, says the investment ‘reflects our belief in the world-class life sciences ...
The Business Times9d
AstraZeneca seeks to move past China probe with Beijing R&D hub
HONG KONG, LONDON] Ever since AstraZeneca shocked investors in October with news its China chief was under investigation, the ...
GEN - Genetic Engineering and Biotechnology News13d
AstraZeneza Commits Up to $11B+ to Chinese Collaborations, Beijing R&D Hub
The largest of the collaborations is a potentially more than $4.68 billion partnership with Shanghai-based Harbour BioMed to ...
NBC Bay Area13d
AstraZeneca to invest $2.5 billion in Beijing hub as it looks beyond Chinese tax probe
AstraZeneca on Friday said that it will invest $2.5 billion in a research and development center in Chinese capital Beijing, months after the British pharmaceutical giant faced local regulators ...